Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04669145 · ClinicalTrials.gov registry record · Phase 2
Regional Anesthesia in Pediatric Orthopaedic Patients
A Phase 2 study, sponsored by Ochsner Health System.
- Completed
- Registry status
- Phase 2
- Development phase
- 24
- Enrollment target
NCT04669145: Completed Phase 2 study, sponsored by Ochsner Health System.
NCT04669145 is a Phase 2 study that has completed, run by Ochsner Health System. The registered enrollment target is 24 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04669145, a Phase 2 study, has completed, sponsored by Ochsner Health System.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 24 participants
- Enrollment target
Study Summary
To identify the benefits from regional anesthesia use as pain management in the pediatric population by delineating the differences in efficacy of continuous nerve blockade versus single-shot techniques after pediatric orthopaedic limb procedures. By doing this, the investigators can determine if specific anesthetic techniques should become a standard of care in pain management for the pediatric population and supersede the need for opioid medication.
Primary Outcome
Amount of opioid medications taken for pain control.
Interventions
- DRUG Ropivacaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2021-06-24 |
| Est. Completion | 2024-04-22 |
| Phase | Phase 2 |
What the finished NCT04669145 record still lists
NCT04669145 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (82% lower).
The record links to 0 conditions, and to 1 intervention - of which Ropivacaine is the first listed.
NCT04669145 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04669145 about?
NCT04669145 is a clinical study titled "Regional Anesthesia in Pediatric Orthopaedic Patients". To identify the benefits from regional anesthesia use as pain management in the pediatric population by delineating the differences in efficacy of continuous nerve blockade versus single-shot techniques after pediatric orthopaedic limb procedures. By doing this, the investigators can determine if sp...
What is the current status of trial NCT04669145?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 24 participants. The study started on 2021-06-24. Estimated completion is 2024-04-22.
What interventions are being tested in trial NCT04669145?
The interventions under investigation include: Ropivacaine (DRUG).
Who is sponsoring clinical trial NCT04669145?
This trial is sponsored by Ochsner Health System, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04669145's enrollment target sits among peer trials
24 1756th of 2000 higher than 217 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI